About: Cyclosporine     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Cyclosporine
rdfs:subClassOf
Concept_In_Subset
Semantic_Type
  • Amino Acid, Peptide, or Protein
  • Pharmacologic Substance
Preferred_Name
  • Cyclosporine
NSC_Code
  • 290193
UMLS_CUI
  • C0010592
CAS_Registry
  • 59865-13-3
Accepted_Therapeutic_Use_For
  • Allogenic transplants; prophylaxis of organ rejection in bone marrow; kidney; liver and heart transplants; psoriasis; rheumatoid arthritis; various diseases that involve autoimmune response
In_Clinical_Trial_For
  • Prevention of bone marrow, organ transplant and stem cell rejection; graft versus host disease in patients with various conditions
  • Prevention of bone marrow; organ transplant and stem cell rejection; graft versus host disease in patients with various conditions
FDA_UNII_Code
  • 83HN0GTJ6D
Contributing_Source
  • FDA
ALT_DEFINITION
  • A drug used to help reduce the risk of rejection of organ and bone marrow transplants by the body. It is also used in clinical trials to make cancer cells more sensitive to anticancer drugs.NCI-GLOSS
PDQ_Open_Trial_Search_ID
  • 39201
PDQ_Closed_Trial_Search_ID
  • 39201
Chemical_Formula
  • C62H111N11O12
Legacy_Concept_Name
  • Cyclosporine
CHEBI_ID
  • CHEBI:4031
FULL_SYN
  • CYCLOSPORINEPTFDA83HN0GTJ6D
  • CiclosporinSYDTPNSC0290193
  • CiclosporinSYNCI
  • CyclosporinSYNCI
  • CyclosporinePTNCI
  • 27-400SYDTPNSC0290193
  • Cyclosporin ASYNCI
  • Cyclosporin ASYDTPNSC0290193
  • CsAABNCI
  • cyclosporinePTNCI-GLOSSCDR0000045187
  • CyclosporinePTDCP00088
  • 27-400CNNCI
  • NeoralBRNCI
  • SangCyaBRNCI
  • OL 27-400CNNCI
  • SandimmunBRNCI
  • SandimmuneBRNCI
DEFINITION
  • A natural cyclic polypeptide immunosuppressant isolated from the fungus Beauveria nivea. The exact mechanism of action of cyclosporine is not known but may involve binding to the cellular protein cytophilin, resulting in inhibition of the enzyme calcineurin. This agent appears to specifically and reversibly inhibit immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited with T-helper cells as the primary target. Cyclosporine also inhibits lymphokine production and release. (NCI04)NCI
code
  • C406
sameAs
http://linked.open...y/mesh/hasConcept
is someValuesFrom of
is sameAs of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 18 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software